Pluri (PLUR) Free Cash Flow (2010 - 2025)
Pluri (PLUR) posted quarterly Free Cash Flow of -$5.7 million for Q4 2025, down 19.24% year-over-year from -$7.0 million in Q4 2024, and down 1.95% quarter-over-quarter from -$5.5 million in Q3 2025.
Pluri (PLUR) Free Cash Flow (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Free Cash Flow for 16 consecutive years, with -$5.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Free Cash Flow fell 19.24% year-over-year to -$5.7 million; the TTM figure through Dec 2025 stood at -$22.0 million (down 24.89% YoY), while the FY2025 annual figure was -$19.8 million, down 8.1% from the prior year.
- Free Cash Flow slipped to -$5.7 million in Q4 2025 per PLUR's latest filing, from -$5.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$3.0 million in Q2 2023 and bottomed at -$9.9 million in Q4 2021.
- Historically, Free Cash Flow has averaged -$6.3 million across 5 years, with a median of -$5.9 million in 2023.
- Annual changes were most pronounced in 2021 — Free Cash Flow slumped 47.39% — and 2023, when it jumped 65.29%.
- Pluri's Free Cash Flow stood at -$9.9 million in 2021, then jumped by 35.83% to -$6.3 million in 2022, then soared by 40.61% to -$3.8 million in 2023, then dropped by 25.73% to -$4.7 million in 2024, then decreased by 19.24% to -$5.7 million in 2025.
- Business Quant data shows PLUR's Free Cash Flow at -$5.7 million in Q4 2025, -$5.5 million in Q3 2025, and -$5.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | -5.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.65 Mn |
| Dec 31, 2025 | -5.65 Mn |
| Sep 30, 2025 | -5.54 Mn |
| Sep 30, 2025 | -5.54 Mn |
| Jun 30, 2025 | -5.94 Mn |
| Jun 30, 2025 | -5.94 Mn |
| Mar 31, 2025 | -4.88 Mn |
| Mar 31, 2025 | -4.88 Mn |
| Dec 31, 2024 | -4.74 Mn |
| Dec 31, 2024 | -4.74 Mn |
| Sep 30, 2024 | -4.27 Mn |
| Sep 30, 2024 | -4.27 Mn |
| Jun 30, 2024 | -4.32 Mn |
| Jun 30, 2024 | -4.32 Mn |
| Mar 31, 2024 | -4.29 Mn |
| Mar 31, 2024 | -4.29 Mn |
| Dec 31, 2023 | -3.77 Mn |
| Dec 31, 2023 | -3.77 Mn |
| Sep 30, 2023 | -5.96 Mn |
| Sep 30, 2023 | -5.96 Mn |